Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 4/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | ECE1 | P42892 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31106917 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL3087602 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL29384229 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL10621114 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL30905102 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL24323603 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL31106850 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL30178287 | 1.00 | MME (0.46) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL3145911 | 0.92 | SMN1; SMN2 (0.50) | MMEACECPA1ACE2SMN1; SMN2 | |
| SCHEMBL783990 | 0.92 | SMN1; SMN2 (0.50) | MMEACECPA1ACE2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5777 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042809-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2026-02-12 | — | — | US | claimed |
| US-20260008820-A1 | ENHANCED PEPTIDE CONSTRUCTS FOR ALBUMIN BINDING | FARBER MICHAEL (US) | 2026-01-08 | — | — | US | claimed |
| EP-4674840-A1 | CHEMICAL COUPLING LINKER AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2026-01-07 | — | — | EP | claimed |
| US-20250170259-A1 | COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC POLYNUCLEOTIDES FOR EXON SKIPPING | YALE UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| WO-2025093774-A1 | GLUCAGON-LIKE PEPTIDE 1 AGONISTS | Constructive Biology Limited (GB) | 2025-05-08 | — | — | WO | claimed |
| WO-2025093566-A2 | A METHOD OF, AND A SYSTEM FOR, GENERATING AN AUDIO OUTPUT FILE VIA A COMPUTER SYSTEM | IAIAI TECHNOLOGIES LIMITED (IE) | 2025-05-08 | — | — | WO | claimed |
| US-20250140223-A1 | METHOD OF, AND A SYSTEM FOR, GENERATING AN AUDIO OUTPUT FILE VIA A COMPUTER SYSTEM | IAIAI TECHNOLOGIES LIMITED (IE) | 2025-05-01 | — | — | US | claimed |
| EP-3632458-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | INST NAT SANTE RECH MED (FR) | 2025-03-19 | — | — | EP | claimed |
| CN-119564878-A | Bioactive substance conjugate, preparation method and application thereof | 苏州宜联生物医药有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119504997-A | Bioactive substance conjugate, preparation method and application thereof | 苏州宜联生物医药有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-117050986-A | CpG oligonucleotide with immune stimulating activity and its use | 南京吉盛澳玛生物医药有限公司 | 2023-11-14 | — | — | CN | claimed |
| WO-2023168427-A1 | COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC POLYNUCLEOTIDES FOR EXON SKIPPING | YALE UNIVERSITY (US) | 2023-09-07 | — | — | WO | claimed |
| WO-2023155808-A1 | CONJUGATE OF ANTIBODY-ERIBULIN OR DERIVATIVE THEREOF, INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 苏州宜联生物医药有限公司 | 2023-08-24 | — | — | WO | claimed |
| WO-2023092926-A1 | NEW POLYPEPTIDE FOR PROMOTING TISSUE REPAIR, AND USE THEREOF | 暨南大学 | 2023-06-01 | — | — | WO | claimed |
| CN-113619400-B | Feedback linearization control method and device for suspension system | 株洲中车时代电气股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-116003529-A | Polypeptide and application thereof in repairing mucous membrane injury or skin injury | 四川好医生攀西药业有限责任公司 | 2023-04-25 | — | — | CN | claimed |
| WO-2023275292-A2 | AEROSOL COMPOSITION FOR PULMONARY DELIVERY OF FLAGELLIN | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-01-05 | — | — | WO | claimed |
| WO-2022221736-A2 | OPTIMIZED TLR7 LIGANDS AND USES THEREOF | GENENTECH, INC. (US) | 2022-10-20 | — | — | WO | claimed |
| WO-2022170971-A1 | BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州宜联生物医药有限公司 | 2022-08-18 | — | — | WO | claimed |
| CN-114807153-A | Multiple CpG oligodeoxynucleotide with immune stimulation activity and application thereof | 南京吉盛澳玛生物医药有限公司 | 2022-07-29 | — | — | CN | claimed |